| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:34597818; PMID:35762964 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:28013214 |
| GO:0001568 | Blood vessel development | Increases phenotype | PMID:37021957 |
| GO:0004022 | Alcohol dehydrogenase (nad+) activity | Decreases phenotype | PMID:34534558 |
| GO:0004053 | Arginase activity | Increases phenotype | PMID:35900689 |
| GO:0004691 | Camp-dependent protein kinase activity | Increases phenotype | PMID:33711355 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:32129097 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:0006694 | Steroid biosynthetic process | Decreases phenotype | PMID:35762964 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:30802670 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:18570050; PMID:30802670; PMID:37364641 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30802670 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:34597818 |
| GO:0008219 | Cell death | Increases phenotype | PMID:33711355 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:24994688; PMID:34428494 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:35739755 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:30802670 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:33711355 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:33711355 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:35900689 |
| GO:0010744 | Positive regulation of macrophage derived foam cell differentiation | Increases phenotype | PMID:26423653 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:35739755; PMID:37364641 |
| GO:0018108 | Peptidyl-tyrosine phosphorylation | Increases phenotype | PMID:33711355 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:39098565 |
| GO:0030728 | Ovulation | Increases phenotype | PMID:33316053 |
| GO:0030850 | Prostate gland development | Decreases phenotype | PMID:30802670 |
| GO:0032308 | Positive regulation of prostaglandin secretion | Increases phenotype | PMID:33316053 |
| GO:0033327 | Leydig cell differentiation | Decreases phenotype | PMID:29325824 |
| GO:0034199 | Activation of protein kinase a activity | Increases phenotype | PMID:37552060 |
| GO:0035116 | Embryonic hindlimb morphogenesis | Decreases phenotype | PMID:24503621 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:32518293 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:28013214; PMID:30802670; PMID:31199487 |
| GO:0035938 | Estradiol secretion | Decreases phenotype | PMID:28013214 |
| GO:0035941 | Androstenedione secretion | Decreases phenotype | PMID:28013214 |
| GO:0035943 | Estrone secretion | Decreases phenotype | PMID:28013214 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:32518293 |
| GO:0036343 | Psychomotor behavior | Affects phenotype | PMID:26108271 |
| GO:0042159 | Lipoprotein catabolic process | Increases phenotype | PMID:26423653 |
| GO:0042161 | Lipoprotein oxidation | Increases phenotype | PMID:26423653 |
| GO:0042221 | Response to chemical | Increases phenotype | PMID:34428494 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:34597818 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:33316053 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:33511402; PMID:35739755; PMID:37364641; PMID:37942807 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:36929940 |
| GO:0045019 | Negative regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:35900689 |
| GO:0045792 | Negative regulation of cell size | Increases phenotype | PMID:29325824 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33711355 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:29325824 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:32518293 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:37364641 |
| GO:0048240 | Sperm capacitation | Increases phenotype | PMID:33711355 |
| GO:0048246 | Macrophage chemotaxis | Increases phenotype | PMID:40323316 |
| GO:0048599 | Oocyte development | Decreases phenotype | PMID:28013214 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:40323316 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:31199487 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:35900689 |
| GO:0060305 | Regulation of cell diameter | Affects phenotype | PMID:37021957 |
| GO:0060376 | Positive regulation of mast cell differentiation | Increases phenotype | PMID:37021957 |
| GO:0060512 | Prostate gland morphogenesis | Decreases phenotype | PMID:31199487 |
| GO:0061107 | Seminal vesicle development | Decreases phenotype | PMID:30802670 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:33983380; PMID:34597818 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:30802670; PMID:37364641 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:24994688; PMID:32129097 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:32518293 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30802670; PMID:33711355 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:35739755 |
| GO:1900015 | Regulation of cytokine production involved in inflammatory response | Affects phenotype | PMID:38954831 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:40323316 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:35900689 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:35739755 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:30842373 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:35900689 |
| GO:1903788 | Positive regulation of glutathione biosynthetic process | Increases phenotype | PMID:37942807 |
| GO:1904177 | Regulation of adipose tissue development | Affects phenotype | PMID:37021957 |
| GO:1904178 | Negative regulation of adipose tissue development | Increases phenotype | PMID:37942807 |
| GO:1904598 | Positive regulation of connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:35739755 |
| GO:1904808 | Positive regulation of protein oxidation | Increases phenotype | PMID:35900689 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:30802670 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:29325824; PMID:35739735 |
| GO:2000611 | Positive regulation of thyroid hormone generation | Increases phenotype | PMID:29734584 |
| GO:2000774 | Positive regulation of cellular senescence | Increases phenotype | PMID:26423653 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:37839492; PMID:39947446 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:37364641 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:37839492 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:37364641 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.